Japan Medical
Tokyo, Japan International Patient Support
Contact Us
Planning a screening visit? Here’s how we can help

Advanced Health Screening in Japan

The smartest plan isn’t the biggest package — it’s the one that fits your actual risk. We help international clients pull together past records, compare self-pay routes in Japan, schedule appointments, get ready for exams, arrange language support and keep the follow-up questions straight.

If you’re already dealing with ongoing symptoms, a new lump, unexplained bleeding, abnormal imaging or a doctor told you to get a closer look — mention it upfront. A targeted workup could do more for you than running through a standard screening package.

Medical imaging used as part of an advanced health assessment in Japan
40–74Age range used for Japan’s Specific Health Checkup framework.
Once a yearRecommended interval for eligible Specific Health Checkups.
5 screening areasNational guidance covers gastric, colorectal, lung, breast and cervical cancer screening.
Why your reason for testing matters

The reason for testing changes what should happen next

Three people can walk in asking for the same checkup and walk out needing completely different plans. Before you pick the equipment, start with what you’re actually trying to figure out.

01

No current symptoms

Build a preventive baseline around age, family history, smoking exposure, metabolic risk and the national cancer-screening schedule.

02

An abnormal result already exists

Use the original report, images and follow-up recommendation to decide whether focused imaging, endoscopy or specialist assessment is more appropriate than repeating a broad package.

03

A known condition is being followed

Monitoring should compare trends against prior results and the treating physician’s plan. Routine screening intervals may no longer apply to the affected organ.

Health screening image supporting review of baseline tests in Japan
First things first: lock in a solid baseline

A useful program starts before MRI or PET-CT

Japan’s Specific Health Checkups define 8 basic groups: questionnaire, body measurements, physical examination, blood pressure, lipids, glucose, liver tests and urine tests. Four additional tests—ECG, eye-fundus examination, anemia testing and serum creatinine—may be added when defined criteria are met. Advanced imaging should answer a separate question, not replace this baseline.

Blood pressure and circulation

Use repeated values, medication history and home readings when available. One reading can be affected by pain, stress, sleep or caffeine.

Glucose and lipid pattern

The MHLW baseline includes fasting glucose or HbA1c, triglycerides, HDL and LDL. Results are more useful when compared with blood pressure, weight, smoking history and previous values.

Liver and urine checks

The standard list includes liver enzymes AST, ALT and gamma-GT plus urine glucose and urine protein. Serum creatinine is one of the conditional additional tests.

Four conditional health-check tests

ECG, eye-fundus examination, anemia testing and serum creatinine may be added under MHLW criteria. Ultrasound, CT, MRI, PET-CT and endoscopy are separate choices and should have a clear reason.

Japan’s national cancer-screening starting point

Use organ-specific screening before adding expensive extras

Japan’s national guidance was updated for implementation in 2026. These are population-screening baselines, not a personal prescription. Symptoms, past cancer, hereditary risk and previous abnormal findings can change the route.

5Nationally recommended cancer-screening categories.
20+Cervical cytology begins from age 20 in the national framework.
40–50+Most other national screening categories begin from age 40 or 50.
AreaNational methodStarting ageIntervalImportant context
GastricGastric X-ray or upper endoscopy50+Every 2 yearsGastric X-ray may temporarily be offered from age 40 annually in some programs.
ColorectalImmunochemical fecal occult blood test40+Every yearA positive result requires diagnostic follow-up; repeating the stool test is not a substitute.
LungQuestionnaire and chest X-ray40+Every yearSmoking exposure can change the discussion about more targeted lung assessment.
BreastMammography with questionnaire40+Every 2 yearsHigh hereditary risk, previous breast cancer or a new lump needs individualized assessment.
CervicalCytology; eligible municipalities may use primary HPV testing20+ cytology; 30+ eligible HPV pathwayEvery 2 years cytology; every 5 years eligible HPV pathwayFollow-up changes when HPV or cytology results are abnormal.

Current reference: National Cancer Center Japan, Cancer Information Service, updated 1 April 2026 from the MHLW guideline revised 24 December 2025. The same guidance notes that screening below the recommended ages has less established benefit and can increase screening harms. Symptoms or a known abnormality should be evaluated as a clinical problem instead of simply moving routine screening earlier.

Got a positive result? Here’s what that actually means

A referral for detailed examination is not a cancer diagnosis

National Cancer Center Japan reports what happened among people referred for detailed examination in 2019. Cancer was ultimately found in a minority of referrals, but follow-up still matters because screening cannot determine the diagnosis by itself.

1.4%–5.6%Range across the five national screening categories among people referred for detailed examination.
About 1 in 18–70Equivalent range depending on the organ screened. These figures apply to referred patients, not everyone screened.

Source: National Cancer Center Japan, based on MHLW 2019 public-health screening data.

Gastric

Usual clarification is upper endoscopy. If a suspicious area is seen, tissue may be taken for pathology.

1.9%
about 1 in 50
Colorectal

Total colonoscopy is the usual first detailed examination; CT colonography or combined methods may be used when colonoscopy is difficult.

3.1%
about 1 in 30
Lung

Chest CT is a common next examination. Tissue or cell sampling may follow when imaging remains suspicious.

2.8%
about 1 in 35
Breast

Additional mammography and ultrasound are commonly combined; cytology or tissue biopsy is used when needed to confirm the finding.

5.6%
about 1 in 18
Cervical

Colposcopy with tissue examination is a common next step; HPV testing or cytology may also be used depending on the result.

1.4%
about 1 in 70
Medical imaging example used to compare CT MRI PET-CT and other screening methods
Match the scan to the question you’re actually asking

CT, MRI, PET-CT and endoscopy do different jobs

Adding every available test increases cost and can create incidental findings. Use each method for a reason you can explain before booking.

CTFast cross-sectional imaging that is useful for selected chest and abdominal questions, but it uses ionizing radiation.
MRI and MRANo ionizing radiation. Brain, vascular and soft-tissue imaging can be useful in selected plans, but implants, metal, claustrophobia and contrast questions must be reviewed.
PET or PET-CTShows areas of increased tracer uptake and can be important in cancer evaluation, but it does not detect every cancer and does not replace Japan’s five organ-specific screening programs.
EndoscopyDirectly examines the digestive tract and may permit biopsy or polyp removal. Preparation, sedation and pathology can change time and cost.
Tumor markersSupport selected clinical questions but can be normal despite cancer or elevated for non-cancer reasons. They are not stand-alone proof.

For a direct comparison, read PET-CT vs. MRI for Cancer Screening.

Not sure how much testing is enough?

Send your age range, priorities, previous reports and preferred dates. We can help you organize the questions before you choose a route.

When a previous finding changes the whole plan

Previous findings and current symptoms can change the whole route

Do not hide an unresolved problem inside a general package. The original finding often tells us which information needs to be organized first.

Abnormal blood result

Send the value, reference range, date and prior trend. One isolated result may need repeat testing before broader investigation.

Imaging nodule or lesion

Send the report and original images when available. Size, location, imaging method and comparison with older scans can matter more than repeating a full-body test.

Positive stool blood test

National guidance calls for appropriate diagnostic follow-up. Repeating a screening stool test does not replace the indicated evaluation.

Known cancer or precancer

National guidance does not treat people currently under care for that cancer or precancer as routine screening candidates for the same organ. The treating physician should decide when screening restarts.

Do not delay local assessment for chest pain, severe shortness of breath, sudden weakness, significant bleeding, rapidly worsening pain or other urgent symptoms in order to travel for screening.
How we help: records, scheduling, and language support

Turn scattered records into a workable plan in Japan

Our role is coordination and language support. Final examination choices, interpretation and clinical decisions remain with the licensed professionals who assess you.

You can also review our Japan Precision Checkup overview.

International health screening coordination and record preparation in Japan

Share the goal and the records you already have

Age, family history, smoking exposure, current medicines, prior operations, recent blood tests, imaging, endoscopy and unresolved recommendations are the useful starting points.

We organize the questions before matching options

We separate preventive screening from findings that may need targeted assessment and identify duplicated or missing information.

Compare scope, timing and planning cost

We help clarify what is included, what is optional, how many days are needed and what can create extra charges.

Coordinate appointment preparation and language needs

We help clarify fasting, bowel preparation when relevant, documents to bring, appointment timing and translation support.

Keep reports and next questions organized

After the visit, the useful outcome is a clear record of what was normal, what needs follow-up, the recommended timing and which report should travel with you.

Real price numbers from public hospital programs

Use current public prices as reference points, not as your quotation

Japan has no single national self-pay price for advanced screening. To avoid false precision, these are current published examples from national medical centers checked in August 2026.

JPY 66,000

Half-day comprehensive checkup

A currently published self-pay example from a national hospital center.

JPY 109,000

One-night, two-day checkup

A broader published example from the same public program.

JPY 132,000

PET-CT examination

A current standalone PET-CT self-pay price published by a national hospital center.

JPY 110,000

PET option example

Another national center lists PET as a Ningen Dock option at this tax-inclusive price.

These are published examples, not a market-wide price range and not a quote for your case. Sedation, pathology, additional imaging, translated reports and follow-up can change the total. See Health Screening Costs and Packages in Japan for a wider package comparison.

Public price sources: half-day and one-night/two-day checkups, PET-CT JPY 132,000, and PET option JPY 110,000.

Want a clearer estimate before you book travel?

Send your preferred dates and the tests or priorities you are considering. We can help you clarify likely scope before the schedule is finalized.

Health screening preparation and medical record review in Japan
Things to sort out before you hit ‘book’

Send the information that can change safety, scope or preparation

Complete information helps reduce duplicated tests and last-minute schedule changes.

Previous reports and original imagesBlood tests, CT, MRI, PET, ultrasound, endoscopy and pathology when available.
Current medicinesEspecially anticoagulants, diabetes medicines and drugs that may affect fasting or procedures.
Family historyEarly cancer, stroke, aneurysm, sudden cardiac death, diabetes or known hereditary disease.
Implants and prior surgeryImportant for MRI safety and for interpreting altered anatomy.
Allergies and contrast historyInclude previous reactions to contrast agents, sedatives or procedure-related medicines.
Pregnancy possibilityMust be disclosed before examinations that may involve ionizing radiation or selected medicines.
Current symptoms or unresolved findingsDo not omit them; they may change the route from routine screening to targeted evaluation.
Preferred language and travel datesUseful for appointment timing, preparation instructions and translation planning.
Read your results by what they tell you to do

A useful report tells you what to do next and when

General health checks may use categories such as monitor, repeat or detailed examination. Cancer screening is simpler: the key distinction is usually whether detailed examination is required. Do not treat “repeat,” “monitor” and “detailed examination” as the same instruction.

Routine intervalNo significant finding in the screened area; continue the recommended future schedule.
MonitorA mild or stable finding may need trend review rather than immediate invasive testing.
RepeatA value or image may need confirmation because of preparation, temporary illness or technical limits.
Detailed examinationA screening result requires a more specific test to clarify whether disease is present.
Direct clinical follow-upA known condition or significant abnormality needs management with the relevant licensed professional.
For cancer screening, “needs detailed examination” should be followed as instructed. National Cancer Center Japan notes that “repeat test” or “observation” is not the standard final cancer-screening category and may refer to a technical repeat or a non-cancer health-check finding.
Follow-up planning after advanced health screening results in Japan
Advanced health screening questions for international clients planning a visit to Japan
Still deciding? Here’s what to check first

Advanced Health Screening in Japan FAQ

What makes a screening plan advanced?
A strong plan combines risk review, a reliable baseline, age-appropriate cancer screening, selected imaging or endoscopy and a defined follow-up route. More tests do not automatically mean better screening.
Can one scan rule out all cancers?
No. Different cancers require different approaches, and some cancers may be too small, slow-growing or poorly shown by a selected imaging method. Japan continues to recommend organ-specific screening for five cancer categories.
Should PET-CT or tumor markers be added automatically?
No. The National Cancer Center Japan notes that CT, PET and tumor-marker options have not been shown to replace the five nationally recommended cancer-screening programs. False-positive and false-negative results remain possible.
What if a previous test is already abnormal?
Send the report, date, original images when available and the previous follow-up recommendation before booking. A focused diagnostic route may be more appropriate than repeating a general package.
How much should I budget?
There is no national fixed price. Current public examples include JPY 66,000 for a half-day comprehensive checkup, JPY 109,000 for a one-night two-day checkup, JPY 132,000 for a standalone PET-CT examination, and JPY 110,000 for a PET option at another national center. Use these as reference points only.
What happens if cancer screening is positive?
It means detailed examination is needed; it does not mean cancer has been confirmed. Common next tests include upper endoscopy for gastric screening, colonoscopy for colorectal screening, chest CT for lung screening, added mammography or ultrasound with tissue sampling for breast screening, and colposcopy with tissue examination for cervical screening.
How much time should I allow?
Published Japanese programs include half-day and one-night two-day checkups. PET-CT or colonoscopy can require extra time, and an abnormal finding may need a separate diagnostic visit. Confirm the actual schedule before booking flights.
Can a normal result guarantee that I am disease-free?
No. Screening only covers the conditions and methods included at that time. False-negative results are possible, and later symptoms should still be assessed promptly.
Where the screening guidance comes from

Public sources used for the screening guidance

Medical guidance and published price examples below were checked against the cited sources on 11 August 2026.

Let’s get the next step sorted

Ready to make your Japan plan clearer?

Share your age range, what matters most to you, any previous findings, the records you have handy, and when you’d like to travel. We can pull it all together, compare the routes that fit, sort out scheduling, and help you get ready for the visit.

This coordination service doesn’t diagnose conditions or replace advice from a licensed physician. The professionals responsible for your care make all examination selections, interpretations and clinical decisions.

WhatsApp+81-8070161366
LINE+81-8075357788